$ARIA Recent Headlines Apple gains on China Mobile deal;

New Post Public Reply Private Reply Replies (0) Message Board

Dec 28, 2013 at 4:01 PM

$ARIA Recent Headlines

Apple gains on China Mobile deal; homebuilders rally 3:33 p.m. Dec. 23, 2013 - Wallace Witkowski
Suspension is lifted for Ariad's leukemia drug 6:33 a.m. Dec. 23, 2013 - MarketWatch.com
J.C. Penney and more of the year's most profitable shorts 3:23 p.m. Dec. 9, 2013 - blogs.marketwatch.com
Hewlett-Packard, a cyclical green light and why silver is in trouble 8:50 a.m. Nov. 26, 2013 - Shawn Langlois
Ariad takes another pounding after leukemia treatment is pulled 12:14 p.m. Oct. 31, 2013 - Russ Britt
H-P has best day in four months on upbeat outlook 3:34 p.m. Oct. 9, 2013 - Sue Chang
Ariad plummets 70% after drug test patients have serious clotting issues 10:38 a.m. Oct. 9, 2013 - Russ Britt
FDA places partial hold on Ariad's Iclusig trials 7:16 a.m. Oct. 9, 2013 - MarketWatch.com
Dan Loeb makes bet on Disney 7:06 p.m. Aug. 14, 2013 - David Benoit
Onyx share surge lifts several boats in biotech harbor, including ETFs 10:33 a.m. July 1, 2013 - Russ Britt
SAC Capital Advisors likes this pharma stock 3:24 p.m. April 18, 2013 - Insider Monkey
Ariad Pharma up 6% to $20.09 10:35 a.m. Dec. 17, 2012 - Steve Gelsi
FDA OKs Iclusig to treat rare types of leukemia 1:06 p.m. Dec. 14, 2012 - MarketWatch.com
Stocks: Investors play the waiting game 8:53 a.m. Dec. 11, 2012 - The Trading Deck
12 biotech stocks hit 52-week highs 2:43 p.m. July 27, 2012 - Val Brickates Kennedy
Three rules for short selling 12:01 a.m. Feb. 2, 2012 - The Trading Deck
Stocks to watch Wednesday: C.R. Bard, Papa John’s 6:52 a.m. Dec. 21, 2011 - MarketWatch
Don't be a fan when investing 8:26 a.m. Dec. 20, 2011 - The Trading Deck
Drug stocks move higher in late trading 2:26 p.m. March 24, 2011 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:12 p.m. Jan. 18, 2011 - Kate Gibson

Mid-Day Market Update: US Markets Turn Lower; Twitter Shares Fall On Analyst Downgrade 12:46 p.m. Dec. 27, 2013 - benzinga.com
Mid-Morning Market Update: Markets Mostly Higher; Textron To Acquire Beechcraft For $1.4B 10:19 a.m. Dec. 27, 2013 - benzinga.com
Ariad Revenue Boosted by Iclusig 12:45 a.m. Dec. 27, 2013 - Barrons.com
Ariad Pharmaceuticals (ARIA): Today's Featured Drugs Laggard 5:01 p.m. Dec. 26, 2013 - TheStreet.com
Update on ARIAD's Iclusig - Analyst Blog 4:45 p.m. Dec. 26, 2013 - Zacks.com
5 Biotechnology Stocks to Buy Now 2:00 a.m. Dec. 25, 2013 - InvestorPlace.com
Ariad Pharmaceuticals (ARIA) Catches Eye: Stock Jumps 8.9% - Tale of the Tape 9:32 a.m. Dec. 24, 2013 - Zacks.com
Credit Suisse raises target but still cautious on Ariad Pharma 1:02 p.m. Dec. 23, 2013 - Seeking Alpha
UPDATE: Credit Suisse Raises PT on Ariad Pharmaceuticals, View Remains Cautious 9:27 a.m. Dec. 23, 2013 - benzinga.com
Heavy Volume And Pre-Market Movement For Ariad Pharmaceuticals (ARIA) 9:24 a.m. Dec. 23, 2013 - TheStreet.com
These Small-Cap BioPharma Companies Have Catalysts Upcoming 8:59 a.m. Dec. 23, 2013 - Seeking Alpha
Don't Buy Ariad Pharmaceuticals Shares At These Levels 8:30 a.m. Dec. 23, 2013 - Seeking Alpha
Ariad rises as sell-side weighs in on new label for Iclusig 8:23 a.m. Dec. 23, 2013 - Seeking Alpha
UPDATE: Bank of America Reiterates on Ariad Pharmaceuticals Following News of Iclusig Re-Launch 8:16 a.m. Dec. 23, 2013 - benzinga.com
Ariad Pharmaceuticals Catches Fire 7:51 a.m. Dec. 23, 2013 - TheStreet.com
UPDATE: Credit Suisse Reiterates on Ariad Pharmaceuticals as Iclusig Re-Launch is Expected to be Bumpy 7:48 a.m. Dec. 23, 2013 - benzinga.com
Benzinga's Top Upgrades 7:48 a.m. Dec. 23, 2013 - benzinga.com
Top Analyst Upgrades and Downgrades: BlackBerry, Five Below, Micron, Tiffany and More 7:45 a.m. Dec. 23, 2013 - 247WallSt.com
Ariad to Resume Selling Iclusig in U.S. 3:18 p.m. Dec. 20, 2013 - WSJ.com
ARIAD Resumes Marketing and Distribution of Iclusig, Investors Getting Some Relief? 12:25 p.m. Dec. 20, 2013 - benzinga.com

FDA Approvals, Stock Price Movements, and Acquisitions - Research Report on ARIAD, Gentium, Salix Pharmaceuticals, NPS Pharmaceuticals, and MEDNAX 8:00 a.m. Dec. 25, 2013 - PR Newswire
Insider Catalyst Report: Ariad Pharmaceuticals, Advanced Micro Devices, Petroleo Brasileiro Petrobras, Endeavor IP Inc 10:32 a.m. Dec. 23, 2013 - ACCESSWIRE
Stock Price Updates, Executive Appointments, Acquisitions, Orphan Drug Designations, and Preclinical Developments - Research Report on Ariad, Halozyme, DepoMed, Omeros, and BioCryst 8:00 a.m. Dec. 23, 2013 - PR Newswire
Technical Research on Equities: Ariad Pharma, MannKind, Galena Biopharma, and Novavax 8:00 a.m. Dec. 23, 2013 - PR Newswire
Bullish Trend Analysis: Ariad Pharmaceuticals, Federal Home Loan Mortgage Corp, NQ Mobile Inc, Micron Technology 11:02 a.m. Dec. 20, 2013 - ACCESSWIRE
ARIAD Announces U.S. Resumption of Marketing and Commercial Distribution of Iclusig (ponatinib) in Refractory Philadelphia-Positive Leukemias 10:10 a.m. Dec. 20, 2013 - BusinessWire
Sector PE Trend, Return On Asset, and Consensus Earnings Forecast for Facebook, Ford Motor, Ariad Pharmaceuticals, Rite Aid, Sirius XM, and Tesla Motors 9:00 a.m. Dec. 20, 2013 - PR Newswire
Traders Buzz: Oracle Corporation, General Electric Company, Ariad Pharmaceuticals, Vertex Pharmaceuticals Incorporated 10:40 a.m. Dec. 19, 2013 - ACCESSWIRE
Published Data, Stock Price Movements, and FDA Approvals - Research Report on Johnson & Johnson, Ariad Pharmaceuticals, PerkinElmer, BD, and Sanofi 8:00 a.m. Dec. 13, 2013 - PR Newswire
Morning Buzz: Facebook Inc, BlackBerry Ltd, Ariad Pharmaceuticals, Nokia Corporation 11:19 a.m. Dec. 12, 2013 - ACCESSWIRE
Stocks Of The Day: Alpha Natural Resources, Apple Inc, Ariad Pharmaceuticals, Verizon Communications 10:40 a.m. Dec. 9, 2013 - ACCESSWIRE
Faruqi & Faruqi, LLP Files Class Action Lawsuit Against ARIAD Pharmaceuticals, Inc. (ARIA) 8:00 p.m. Dec. 6, 2013 - PR Newswire
UPCOMING DEADLINE: Levi & Korsinsky, LLP Announces Class Action Against ARIAD Pharmaceuticals, Inc. and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013 -- ARIA 6:11 p.m. Dec. 5, 2013 - PR Newswire
Blue Chip Stock News: Ariad Pharmaceuticals, Citigroup Inc, Arena Pharmaceuticals, Market Vectors Gold Miners 9:45 a.m. Dec. 5, 2013 - ACCESSWIRE
Stock Price Movements, Campaigns, New Clinical Studies, and Approvals- Research Report on Actavis, Ariad Pharmaceuticals, DaVita, Celldex, and WellCare 8:00 a.m. Dec. 5, 2013 - PR Newswire
MolecularMD Announces Presentations at Upcoming American Society of Hematology Annual Meeting 7:00 a.m. Dec. 5, 2013 - Marketwire
Labaton Sucharow LLP Has Filed a Class Action Lawsuit on Behalf of Investors in Ariad Pharmaceuticals, Inc. -- ARIA 6:28 p.m. Dec. 3, 2013 - GlobeNewswire
ARIAD Announces Iclusig Data Presentations at Annual American Society of Hematology Meeting 7:35 a.m. Dec. 3, 2013 - BusinessWire
TrendingWallStreet.com Reports Volume Coverage on ZOOM, FARE, BAC, and ARIA 12:26 a.m. Dec. 3, 2013 - ACCESSWIRE
ARIA, AAPL, EBAY and CAMT added to NASDAQ Active Stock Watch List at EPR 10:34 a.m. Dec. 2, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Solar Fencing Revolutionizes North Texas Homes

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Finastra Recognized as 2026 Leader in Payment Platforms

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

ScholarShare 529 Launches $50 Back-to-School Promo

California Families Get a Boost With New 529 Plan Offer Everywhere you turn, it's 'back to school' mania right now, and ScholarShare 529 aims to ride that wave by sweetening the pot for parents ready to think ahead. So here's the gist—California's official college savings plan is handing out a $50 gift card for new accounts opened between now and September 30th. Setting...

Jacob Walthour to Be Honored for Economic Leadership

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Koogler's Sale to ALL4: A Game-Changer for the Southeast

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

OrthoAtlanta Expands with Dr. Smith's Expertise Hire

OrthoAtlanta Welcomes New Orthopedic Surgeon In a world where healthcare organizations are constantly stretching their wings, this new addition of Dr. Carson J. Smith to the fold at Piedmont Orthopedics | OrthoAtlanta stands out. This isn't just some cosmetic face-lift, folks. It's a real investment in the community, not to mention a crucial broadening of what this...

2026 CEE Awards Highlight Energy Innovation Leaders

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Ransoms and Mega-Losses Surge in Cyber Claims Study

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Lyric Health's AI System Promises Data-Driven Revolution

A Bold Step in Healthcare Coordination No doubt about it, healthcare is a mess. It's like trying to patch a leaking ship with duct tape—point solutions here, add-ons there, and nothing truly working in harmony. And in storms in Lyric Health, claiming they've got the answer. They've launched an AI-powered Healthcare Operating System meant to unify these disjointed pieces...